[ {
  "sentence_tokens" : [ "Ridaforolimus", "(", "AP23573", ",", "MK-8669", ")", "is", "a", "specific", "inhibitor", "of", "the", "mammalian", "target", "of", "rapamycin", "(", "mTOR", ")", ",", "a", "serine/threonine", "kinase", "that", "has", "a", "key", "role", "in", "integrating", "intracellular", "signals", "necessary", "for", "cell", "growth", ",", "metabolism", ",", "and", "survival", "[", "6", ",", "15", "]", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 12, 13, 14, 15, 16 ],
  "trigger_indices" : [ 6, 7, 8, 9, 10 ],
  "rule_name" : "Negative_activation_copula_1",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "categorical", "analyses", "of", "QTcF", "and", "change", "from", "baseline", "in", "QTcF", "further", "support", "the", "conclusion", "that", "ridaforolimus", "does", "not", "prolong", "QTcF", "." ],
  "event_indices" : [ 16, 17, 18, 19, 20, 21 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 16, 17 ],
  "controlled_indices" : [ 20, 21 ],
  "trigger_indices" : [ 19, 20 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "other", "patient", "took", "a", "protocol", "violating", "medication", "(", "CYP3A4", "inducer", "pioglitazone", ")", ";", "however", ",", "for", "day", "1", "(", "placebo", "day", ")", ",", "it", "was", "determined", "that", "this", "medication", "did", "not", "preclude", "the", "patient", "'", "s", "Holter", "data", "from", "being", "included", ",", "since", "ridaforolimus", "was", "not", "administered", "on", "day", "1", "." ],
  "event_indices" : [ 9, 10, 11, 12 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 11, 12 ],
  "controlled_indices" : [ 9, 10 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_token_1_noun",
  "rule" : null
}, {
  "sentence_tokens" : [ "Administration", "of", "the", "single", "100-mg", "dose", "of", "ridaforolimus", "did", "not", "cause", "a", "clinically", "meaningful", "prolongation", "of", "QTcF", ",", "suggesting", "that", "patients", "treated", "with", "ridaforolimus", "have", "a", "low", "likelihood", "of", "delayed", "ventricular", "repolarization", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 16, 17 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Administration", "of", "the", "single", "100-mg", "dose", "of", "ridaforolimus", "did", "not", "cause", "a", "clinically", "meaningful", "prolongation", "of", "QTcF", ",", "suggesting", "that", "patients", "treated", "with", "ridaforolimus", "have", "a", "low", "likelihood", "of", "delayed", "ventricular", "repolarization", "." ],
  "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 7, 8 ],
  "controlled_indices" : [ 30, 31, 32 ],
  "trigger_indices" : [ 10, 11 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "This", "dedicated", "QTc", "study", "was", "designed", "to", "evaluate", "the", "effect", "of", "the", "mammalian", "target", "of", "rapamycin", "inhibitor", ",", "ridaforolimus", ",", "on", "the", "QTc", "interval", "in", "patients", "with", "advanced", "malignancies", "." ],
  "entity_one_indices" : [ 18, 19 ],
  "entity_two_indices" : [ 12, 13, 14, 15, 16, 17 ]
}, {
  "sentence_tokens" : [ "Holter", "electrocardiogram", "(", "ECG", ")", "monitoring", "was", "performed", "for", "24", "h", "after", "each", "treatment", ",", "and", "blood", "ridaforolimus", "concentrations", "were", "measured", "for", "24", "h", "after", "dosing", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 3, 4 ]
}, {
  "sentence_tokens" : [ "Ridaforolimus", "has", "also", "displayed", "promising", "activity", "in", "phase", "1", "and", "phase", "2", "clinical", "trials", "in", "patients", "with", "advanced", "sarcoma", "and", "other", "malignancies", "[", "11", ",", "17", ",", "20", ",", "22", "]", "." ],
  "entity_one_indices" : [ 18, 19 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Electrocardiogram", "(", "ECG", ")", "monitoring", "during", "phase", "1", "and", "phase", "2", "clinical", "trials", "of", "ridaforolimus", "did", "not", "identify", "a", "risk", "of", "QTc", "prolongation", "." ],
  "entity_one_indices" : [ 14, 15 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "Part", "1", "had", "a", "fixed-sequence", ",", "single-blind", ",", "placebo", "controlled", "design", "consisting", "of", "2", "days", "of", "intensive", "ECG", "monitoring", "for", "QTc", "assessment", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 0, 1, 2 ]
}, {
  "sentence_tokens" : [ "Patients", "received", "ridaforolimus", "40", "mg", "once", "daily", "for", "5", "consecutive", "days", "every", "week", "until", "disease", "progression", ",", "unacceptable", "toxicity", ",", "or", "withdrawal", "from", "the", "study", "." ],
  "entity_one_indices" : [ 14, 15, 16 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "Holter", "ECG", "monitoring", "was", "performed", "for", "24", "h", "after", "each", "dose", "in", "part", "1", "using", "a", "Mortara", "H12+", "digital", "Holter", "recorder", "." ],
  "entity_one_indices" : [ 16, 17, 18, 19, 20, 21 ],
  "entity_two_indices" : [ 1, 2 ]
}, {
  "sentence_tokens" : [ "The", "geometric", "mean", "C", "of", "ridaforolimus", "was", "186", "ng/mL", "(", "95", "%", "CI", ":", "159", ",", "218", ")", ",", "and", "the", "median", "T", "was", "4.2", "h", "after", "dosing", "(", "Table", "2", ")", "." ],
  "entity_one_indices" : [ 12, 13 ],
  "entity_two_indices" : [ 5, 6 ]
}, {
  "sentence_tokens" : [ "The", "largest", "placebo", "corrected", "change", "from", "baseline", "occurred", "10", "h", "after", "dosing", ",", "with", "a", "mean", "difference", "of", "3.89", "ms", "(", "90", "%", "CI", ":", "0.60", ",", "7.17", ")", "in", "QTcF", "change", "from", "baseline", "after", "ridaforolimus", "versus", "placebo", "administration", "." ],
  "entity_one_indices" : [ 35, 36 ],
  "entity_two_indices" : [ 23, 24 ]
}, {
  "sentence_tokens" : [ "The", "appropriateness", "of", "using", "QTcF", "was", "evaluated", "graphically", "and", "by", "simple", "linear", "regression", "of", "QTcF", "versus", "RR", "interval", "using", "the", "placebo", "data", ":", "the", "estimated", "slope", "from", "the", "regression", "was", "0.0060", "(", "95", "%", "CI", ":", "-", "0.0069", ",", "0.0190", ")", ",", "suggesting", "that", "Fridericia", "'", "s", "correction", "method", "was", "adequate", "." ],
  "entity_one_indices" : [ 34, 35 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "In", "part", "1", ",", "a", "single", "100-mg", "dose", "of", "ridaforolimus", "was", "generally", "well", "tolerated", "by", "patients", "with", "advanced", "cancer", ";", "no", "patient", "discontinued", "treatment", "due", "to", "an", "AE", "." ],
  "entity_one_indices" : [ 27, 28 ],
  "entity_two_indices" : [ 9, 10 ]
}, {
  "sentence_tokens" : [ "Thrombocytopenia", "and", "fatigue", "(", "each", "in", "2", "patients", ";", "9.1", "%", ")", "were", "the", "most", "common", "grade", "3", "events", ";", "no", "grade", "4", "events", "were", "reported", "." ],
  "entity_one_indices" : [ 2, 3 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Five", "patients", "(", "22.7", "%", ")", "required", "dose", "modifications", "until", "resolution", "or", "improvement", "of", "treatment", "related", "AEs.Serious", "AEs", "were", "reported", "in", "8", "patients", "(", "36.4", "%", ")", ",", "including", "2", "(", "9.1", "%", ")", "with", "events", "considered", "related", "to", "treatment", "(", "viral", "bronchitis", "and", "pneumonitis", ")", "." ],
  "entity_one_indices" : [ 42, 43 ],
  "entity_two_indices" : [ 17, 18 ]
}, {
  "sentence_tokens" : [ "Four", "patients", "(", "17.4", "%", ")", "had", "elevated", "glucose", ",", "which", "is", "known", "to", "be", "associated", "with", "mTOR", "inhibition", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 8, 9 ]
}, {
  "sentence_tokens" : [ "The", "upper", "bound", "of", "the", "90", "%", "CI", "of", "the", "placebo", "corrected", "mean", "QTcF", "change", "from", "baseline", "was", "<", "10", "ms", "at", "every", "time", "point", "measured", "during", "the", "24-h", "evaluation", "period", "." ],
  "entity_one_indices" : [ 13, 14 ],
  "entity_two_indices" : [ 7, 8 ]
}, {
  "sentence_tokens" : [ "Only", "one", "patient", "had", "a", "QTcF", "interval", ">", "450", "ms", ",", "which", "was", "observed", "after", "both", "placebo", "and", "ridaforolimus", ";", "no", "patient", "had", "a", "QTcF", ">", "480", "ms", "or", "change", "from", "baseline", ">", "30", "ms.", "Whole-blood", "pharmacokinetics", "of", "ridaforolimus", "were", "also", "determined", "over", "the", "24-h", "period", "after", "dosing", "." ],
  "entity_one_indices" : [ 38, 39 ],
  "entity_two_indices" : [ 18, 19 ]
}, {
  "sentence_tokens" : [ "Individual", "QTcF", "changes", "from", "baseline", "versus", "ridaforolimus", "blood", "concentrations", "revealed", "no", "clear", "concentration", "-", "time", "relationship", "." ],
  "entity_one_indices" : [ 6, 7 ],
  "entity_two_indices" : [ 1, 2 ]
}, {
  "sentence_tokens" : [ "These", "findings", "suggest", "that", "ridaforolimus", "is", "not", "likely", "to", "cause", "a", "clinically", "meaningful", "prolongation", "of", "the", "QTc", "interval", "in", "patients", "with", "cancer.Since", "this", "study", "evaluated", "ridaforolimus", "in", "an", "advanced", "cancer", "population", ",", "its", "design", "was", "modified", "from", "the", "thorough", "QT/QTc", "study", "recommended", "in", "E14", "guidance", "." ],
  "entity_one_indices" : [ 25, 26 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "Similar", "to", "other", "rapamycin", "analogs", "[", "12", ",", "14", ",", "16", "]", ",", "ridaforolimus", "exhibits", "saturable", "binding", "to", "erythrocytes", ",", "which", "may", "be", "an", "important", "contributor", "to", "the", "drug", "'", "s", "nonlinear", "whole-blood", "pharmacokinetics", ",", "with", "less", "than", "proportional", "increases", "in", "whole-blood", "exposure", "following", "oral", "or", "IV", "administration", "[", "8,", "17", ",", "18", "]", "." ],
  "entity_one_indices" : [ 13, 14 ],
  "entity_two_indices" : [ 3, 4 ]
}, {
  "sentence_tokens" : [ "Third", ",", "higher", "single", "doses", "were", "not", "administered", "because", "they", "would", "not", "have", "provided", "proportionally", "higher", "exposure", "given", "the", "nonlinear", "blood", "pharmacokinetics", "of", "ridaforolimus.Adverse", "events", "observed", "in", "this", "study", "were", "consistent", "with", "the", "known", "safety", "profile", "of", "ridaforolimus", "in", "other", "clinical", "studies", ",", "as", "well", "as", "the", "safety", "profiles", "of", "other", "mTOR", "inhibitors", "." ],
  "entity_one_indices" : [ 51, 52, 53 ],
  "entity_two_indices" : [ 37, 38 ]
}, {
  "sentence_tokens" : [ "To", "date", ",", "preclinical", "studies", "with", "ridaforolimus", ",", "as", "well", "as", "the", "safety", "database", "for", "ridaforolimus", "in", "cancer", "patients", ",", "have", "shown", "no", "signal", "for", "QTc", "prolongation", "." ],
  "entity_one_indices" : [ 15, 16 ],
  "entity_two_indices" : [ 6, 7 ]
}, {
  "sentence_tokens" : [ "Results", "from", "this", "study", "are", "consistent", "with", "a", "preclinical", "risk", "assessment", "made", "on", "the", "basis", "of", "current", "ICH", "S7A", "and", "S7B", "guidelines", "[", "1", "]", "." ],
  "entity_one_indices" : [ 20, 21, 22, 23, 24, 25 ],
  "entity_two_indices" : [ 17, 18 ]
}, {
  "sentence_tokens" : [ "The", "hERG", "channel", "was", "only", "minimally", "inhibited", "at", "the", "highest", "ridaforolimus", "concentration", "tested", "(", "5", "%", "inhibition", "at", "50", "mu", "M", ")", "." ],
  "entity_one_indices" : [ 10, 11 ],
  "entity_two_indices" : [ 1, 2 ]
}, {
  "sentence_tokens" : [ "The", "present", "data", "with", "a", "single", "100-mg", "oral", "dose", "indicate", "that", "ridaforolimus", "has", "a", "low", "likelihood", "of", "causing", "delayed", "ventricular", "repolarization", "." ],
  "entity_one_indices" : [ 19, 20, 21 ],
  "entity_two_indices" : [ 11, 12 ]
}, {
  "sentence_tokens" : [ "Because", "exposure", "to", "ridaforolimus", "after", "this", "single", "dose", "approximates", "the", "exposure", "at", "steady-state", "with", "the", "40-mg", "therapeutic", "regimen", ",", "treatment", "with", "ridaforolimus", "is", "not", "likely", "to", "cause", "a", "clinically", "meaningful", "prolongation", "of", "the", "QTc", "interval", "in", "patients", "with", "cancer", "." ],
  "entity_one_indices" : [ 21, 22 ],
  "entity_two_indices" : [ 3, 4 ]
} ]